Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Expressing the sense of Congress relating to nuclear power being a necessary clean baseload energy source to achieve a reliable, secure, and green electric grid.
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.2226, HR.2670, HR.124, H.Con.Res.26, S.111, HR.1007, HR.1042, S.459, S.571, S.763
Expressing the sense of Congress relating to nuclear power being a necessary clean baseload energy source to achieve a reliable, secure, and green electric grid.
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2024 · second_quarter · 2T
N/A
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2024 · first_quarter · Q1
Source: Senate LDA
| SHELL OIL COMPANY |
| 29 |
| 2009–2016 |
| PHRMA | 26 | 2017–2024 |
| GRAIL, Inc. | 17 | 2020–2024 |
| BUILDING AND CONSTRUCTION TRADES COUNCIL OF GREATER NEW YORK | 9 | 2012–2016 |
| NEW ENGLAND TEAMSTERS & TRUCKING INDUSTRY PENSION FUND | 9 | 2010–2014 |
| CHANGE TO WIN FEDERATION | 8 | 2007–2011 |
| INTERNATIONAL BROTHERHOOD OF TEAMSTERS | 8 | 2008–2009 |
| SOUNDEXCHANGE | 8 | 2008–2010 |
| TRANSCANADA PIPELINES, LTD | 7 | 2008–2009 |
| LYONDELL CHEMICAL COMPANY | 5 | 2009 |
| EXPRESS SCRIPTS INC | 4 | 2011–2012 |
| ALTRIA CLIENT SERVICES LLC FKA ALTRIA | 1 | 2020 |
| CHICAGO BRIDGE & IRON COMPANY N V | 1 | 2014 |
| MATHIS GROUP (FORMERLY REGISTERED AS MICHAEL MATHIS) | 1 | 2007 |
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
Nuclear Assistance for America’s Small Businesses Act
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
Nuclear Assistance for America’s Small Businesses Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.2226, HR.2670, HR.124, H.Con.Res.26, S.111, HR.1007, HR.1042, S.459, S.571, S.763
Prohibiting Russian Uranium Imports Act
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
Prohibiting Russian Uranium Imports Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.2226, HR.2670, HR.124, H.Con.Res.26, S.111, HR.1007, HR.1042, S.459, S.571, S.763
Nuclear Waste Informed Consent Act
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.2226, HR.2670, HR.124, H.Con.Res.26, S.111, HR.1007, HR.1042, S.459, S.571, S.763
Emergency and Disaster Preparedness for Farm Animals Act
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
National Defense Authorization Act for Fiscal Year 2024
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
National Defense Authorization Act for Fiscal Year 2024
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.2226, HR.2670, HR.124, H.Con.Res.26, S.111, HR.1007, HR.1042, S.459, S.571, S.763
Continuing Appropriations Act, 2024 and Other Extensions Act
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
Extension of Continuing Appropriations and Other Matters Act, 2024
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
Providing Accountability Through Transparency Act of 2023
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.2226, HR.2670, HR.124, H.Con.Res.26, S.111, HR.1007, HR.1042, S.459, S.571, S.763
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Price Controls, Intellectual Property Rights S.127, S.113, S.1339
Pharmacy Benefit Manager Transparency Act of 2023
Client: PILMA · Firm: THE MATHIS HARPLE GROUP
Price Controls, Intellectual Property Rights S.127, S.113, S.1339
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHRMA · Firm: THE MATHIS HARPLE GROUP
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Price Controls, Intellectual Property Rights S.127, S.113, S.1339
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Civil Nuclear Export Act of 2023
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
National Defense Authorization Act for Fiscal Year 2024
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.2226, HR.2670, HR.124, H.Con.Res.26, S.111, HR.1007, HR.1042, S.459, S.571, S.763
National Defense Authorization Act for Fiscal Year 2024
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
Thin Blue Line Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.2226, HR.2670, HR.124, H.Con.Res.26, S.111, HR.1007, HR.1042, S.459, S.571, S.763
A bill to require reports on the dangers posed by nuclear reactors in areas that might experience armed conflict.
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.2226, HR.2670, HR.124, H.Con.Res.26, S.111, HR.1007, HR.1042, S.459, S.571, S.763
A bill to require reports on the dangers posed by nuclear reactors in areas that might experience armed conflict.
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
Reduce Russian Uranium Imports Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.2226, HR.2670, HR.124, H.Con.Res.26, S.111, HR.1007, HR.1042, S.459, S.571, S.763
Reduce Russian Uranium Imports Act
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
A resolution expressing the sense of the Senate that the President and the Secretary of State should ensure that the Government of Canada does not permanently store nuclear waste in the Great Lakes Basin.
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
Expressing the sense of Congress relating to nuclear power being a necessary clean baseload energy source to achieve a reliable, secure, and green electric grid.
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S.452; S. 111; S. 826
Expressing the sense of Congress relating to nuclear power being a necessary clean baseload energy source to achieve a reliable, secure, and green electric grid.
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S.452; S. 826
Expressing the sense of Congress relating to nuclear power being a necessary clean baseload energy source to achieve a reliable, secure, and green electric grid.
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S. 826
Freedom to Breathe Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR. 5401
Freedom to Breathe Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR5401
Freedom to Breathe Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368
Freedom to Breathe Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR5401
Freedom to Breathe Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR. 5401
9/11 Memorial and Museum Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR. 5401
9/11 Memorial and Museum Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR5401
9/11 Memorial and Museum Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR5401
9/11 Memorial and Museum Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR. 5401
Building Resilient Supply Chains Act
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res; 26; S.452; S. 111; S. 826
Building Resilient Supply Chains Act
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res; 26; S.452; S. 111; S. 826
Building Resilient Supply Chains Act
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S. 826
Building Resilient Supply Chains Act
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S.452; S. 111; S. 826
Building Resilient Supply Chains Act
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S.452; S. 826
Expressing the sense of the House of Representatives that the United States should support the expansion of domestic nuclear energy and advanced nuclear technology as a viable source of power in order to promote United States nuclear energy leadership and global energy independence.
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res; 26; S.452; S. 111; S. 826
Expressing the sense of the House of Representatives that the United States should support the expansion of domestic nuclear energy and advanced nuclear technology as a viable source of power in order to promote United States nuclear energy leadership and global energy independence.
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S.452; S. 826
Expressing the sense of the House of Representatives that the United States should support the expansion of domestic nuclear energy and advanced nuclear technology as a viable source of power in order to promote United States nuclear energy leadership and global energy independence.
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S. 826
Expressing the sense of the House of Representatives that the United States should support the expansion of domestic nuclear energy and advanced nuclear technology as a viable source of power in order to promote United States nuclear energy leadership and global energy independence.
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res; 26; S.452; S. 111; S. 826
Expressing the sense of the House of Representatives that the United States should support the expansion of domestic nuclear energy and advanced nuclear technology as a viable source of power in order to promote United States nuclear energy leadership and global energy independence.
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S.452; S. 111; S. 826
Providing Accountability Through Transparency Act of 2023
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S.452; S. 111; S. 826
Providing Accountability Through Transparency Act of 2023
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res; 26; S.452; S. 111; S. 826
Providing Accountability Through Transparency Act of 2023
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res; 26; S.452; S. 111; S. 826
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHRMA · Firm: THE MATHIS HARPLE GROUP
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHRMA · Firm: THE MATHIS HARPLE GROUP
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHRMA · Firm: THE MATHIS HARPLE GROUP
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Multi-Cloud Innovation and Advancement Act of 2023
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR. 5401
Multi-Cloud Innovation and Advancement Act of 2023
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR5401
Multi-Cloud Innovation and Advancement Act of 2023
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR. 5401
Multi-Cloud Innovation and Advancement Act of 2023
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368
Multi-Cloud Innovation and Advancement Act of 2023
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR5401
DEFUND Act of 2023
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR. 5401
DEFUND Act of 2023
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR. 5401
DEFUND Act of 2023
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368
DEFUND Act of 2023
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR5401
DEFUND Act of 2023
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR5401
Nuclear Fuel Security Act of 2023
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S.452; S. 826
Nuclear Fuel Security Act of 2023
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res; 26; S.452; S. 111; S. 826
Nuclear Fuel Security Act of 2023
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res; 26; S.452; S. 111; S. 826
Nuclear Fuel Security Act of 2023
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S.452; S. 111; S. 826
International Nuclear Energy Act of 2023
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S. 826
International Nuclear Energy Act of 2023
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S.452; S. 826
International Nuclear Energy Act of 2023
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res; 26; S.452; S. 111; S. 826
International Nuclear Energy Act of 2023
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res; 26; S.452; S. 111; S. 826
International Nuclear Energy Act of 2023
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR. 762; H. Res 124; H. Con. Res 26; S.452; S. 111; S. 826
United States Innovation and Competition Act of 2021
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR.5376, HR.8294, HR.8240, HR.7900, HR.7403, HR.7222, HR.6874, HR. 4521, HR. 6901 S. 1260, S. 3741
United States Innovation and Competition Act of 2021
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR.5376, HR.8240, HR. 7222, HR. 4521, HR. 6901 S. 1605, S. 1260, S. 3741, S. RES.514
United States Innovation and Competition Act of 2021
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR.5376, HR.8294, HR.8240, HR.7900, HR.7403, HR.7222, HR.6874, HR. 4521, HR. 6901 S. 1605, S. 1260, S. 3741,
Investing in Energy Regions Act
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
S.3023, S.3428, S.2896, HR.5401, HR. 5368, S.2871
Investing in Energy Regions Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR.5401
Investing in Energy Regions Act
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR.5401
Inflation Reduction Act of 2022
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR.5376, HR.8294, HR.8240, HR.7900, HR.7403, HR.7222, HR.6874, HR. 4521, HR. 6901 S. 1605, S. 1260, S. 3741,
Inflation Reduction Act of 2022
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR.5376, HR.8294, HR.8240, HR.7900, HR.7403, HR.7222, HR.6874, HR. 4521, HR. 6901 S. 1260, S. 3741
Inflation Reduction Act of 2022
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR.5376, HR.8240, HR. 7222, HR. 4521, HR. 6901 S. 1605, S. 1260, S. 3741, S. RES.514
Nuclear Waste Task Force Act of 2021
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR.5401
Nuclear Waste Task Force Act of 2021
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
S.3023, S.3428, S.2896, HR.5401, HR. 5368, S.2871
Nuclear Waste Task Force Act of 2021
Client: CONSTELLATION ENERGY GENERATION, LLC · Firm: THE MATHIS HARPLE GROUP
S.3428, S.2871, HR.5368, HR.5401
American Energy for Europe Act
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR.5376, HR.8294, HR.8240, HR.7900, HR.7403, HR.7222, HR.6874, HR. 4521, HR. 6901 S. 1605, S. 1260, S. 3741,
American Energy for Europe Act
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR.5376, HR.8294, HR.8240, HR.7900, HR.7403, HR.7222, HR.6874, HR. 4521, HR. 6901 S. 1260, S. 3741
To prohibit the use of Federal funds for the private interim storage of spent nuclear fuel, and for other purposes.
Client: NUCLEAR ENERGY INSTITUTE · Firm: THE MATHIS HARPLE GROUP
HR.5376, HR.8294, HR.8240, HR.7900, HR.7403, HR.7222, HR.6874, HR. 4521, HR. 6901 S. 1260, S. 3741
S.2226, HR.2670, HR.124, H.Con.Res.26, S.111, HR.1007, HR.1042, S.459, S.571, S.763
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2024 · first_quarter · Q1
HR. 5860; HR. 7463; S.2226; HR.2670; HR.124; H.Con.Res. 26; S.1111; HR.1007; HR.1042; S.459; S.571; S.763; S.1928; HR.1051; HR.243; S.Res.117
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2024 · first_quarter · Q1
Price Controls, Intellectual Property Rights S.127, S.113, S.1339
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2024 · first_quarter · Q1
Development and Implementation of a process to support early detection of cancer.
Development and implementation of a process to support early detection of cancer
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2024 · first_quarter · Q1
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2023 · fourth_quarter · Q4
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2023 · third_quarter · 3A
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2023 · fourth_quarter · Q4
HR. 762; H. Res 124; H. Con. Res 26; S. 826
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2023 · third_quarter · 3A
HR. 762; H. Res 124; H. Con. Res 26; S.452; S. 826
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2023 · fourth_quarter · Q4
Development and Implementation of a process to support early detection of cancer.
Development and implementation of a process to support early detection of cancer
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2023 · fourth_quarter · 4A
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2023 · fourth_quarter · Q4
S.3428, S.2871, HR.5368, HR. 5401
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2023 · third_quarter · 3A
S.3428, S.2871, HR.5368, HR. 5401
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2023 · fourth_quarter · Q4
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2023 · third_quarter · Q3
HR. 762; H. Res 124; H. Con. Res 26; S.452; S. 111; S. 826
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2023 · third_quarter · Q3
Price Controls, Intellectual Property Rights S.127 S.113 S.1339
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2023 · third_quarter · Q3
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2023 · third_quarter · Q3
Development and Implementation of a process to support early detection of cancer.
Development and implementation of a process to support early detection of cancer
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2023 · third_quarter · Q3
S.3428, S.2871, HR.5368
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2023 · second_quarter · Q2
Development and implementation of a process to support early detection of cancer
Development and Implementation of a process to support early detection of cancer.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2023 · second_quarter · Q2
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2023 · second_quarter · Q2
S.3428, S.2871, HR.5368, HR5401
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2023 · second_quarter · Q2
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2023 · second_quarter · Q2
HR. 762; H. Res 124; H. Con. Res; 26; S.452; S. 111; S. 826
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2023 · first_quarter · Q1
S.3428, S.2871, HR.5368, HR5401
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2023 · first_quarter · Q1
Development and Implementation of a process to support early detection of cancer.
Development and implementation of a process to support early detection of cancer
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2023 · first_quarter · Q1
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2023 · first_quarter · Q1
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2023 · first_quarter · Q1
HR. 762; H. Res 124; H. Con. Res; 26; S.452; S. 111; S. 826
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2022 · fourth_quarter · Q4
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2022 · fourth_quarter · Q4
HR.5376, HR.8294, HR.8240, HR.7900, HR.7403, HR.7222, HR.6874, HR. 4521, HR. 6901 S. 1260, S. 3741
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2022 · fourth_quarter · Q4
Provide coverage of the costs of the Grail early cancer detection process.
Development and implementation of a process to support early detection of cancer
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2022 · fourth_quarter · Q4
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PMI GLOBAL SERVICES INC. via THE MATHIS HARPLE GROUP
2022 · fourth_quarter · 4T
Taxation of Modified Risk Tobacco Products
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2022 · third_quarter · Q3
HR.5376, HR.8294, HR.8240, HR.7900, HR.7403, HR.7222, HR.6874, HR. 4521, HR. 6901 S. 1605, S. 1260, S. 3741,
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PMI GLOBAL SERVICES INC. via THE MATHIS HARPLE GROUP
2022 · third_quarter · Q3
Taxation of Modified Risk Tobacco Products
GRAIL, INC via THE MATHIS HARPLE GROUP
2022 · third_quarter · Q3
Provide coverage of the costs of the Grail early cancer detection process.
Development and implementation of a process to support early detection of cancer
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2022 · third_quarter · Q3
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2022 · third_quarter · Q3
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2022 · second_quarter · Q2
Development and implementation of a process to support early detection of cancer.
Provide coverage of the costs of the Grail early cancer detection process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2022 · second_quarter · Q2
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2022 · second_quarter · Q2
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2022 · second_quarter · Q2
HR.5376, HR.8240, HR. 7222, HR. 4521, HR. 6901 S. 1605, S. 1260, S. 3741, S. RES.514
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PMI GLOBAL SERVICES INC. via THE MATHIS HARPLE GROUP
2022 · second_quarter · Q2
Taxation of Modified Risk Tobacco Products
PILMA via THE MATHIS HARPLE GROUP
2022 · first_quarter · 1A
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2022 · first_quarter · Q1
Development and implementation of a process to support early detection of cancer.
Provide coverage of the costs of the Grail early cancer detection process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2022 · first_quarter · Q1
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PMI GLOBAL SERVICES INC. via THE MATHIS HARPLE GROUP
2022 · first_quarter · Q1
Taxation of Modified Risk Tobacco Products
PILMA via THE MATHIS HARPLE GROUP
2022 · first_quarter · Q1
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2022 · first_quarter · Q1
S.3428, S.2871, HR.5368, HR.5401
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2022 · first_quarter · Q1
S.3023, S.3428, S.2896, HR.5401, HR. 5368, S.2871
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2022 · first_quarter · RA
S.3428, S.2871, HR.5368, HR.5401
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2021 · fourth_quarter · 4A
S.3428, S.2871, HR.5368, HR.5401
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2021 · fourth_quarter · 4A
S.3023, S.3428, S.2896, HR.5401, HR. 5368, S.2871
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2021 · fourth_quarter · Q4
Provide coverage of the costs of the Grail early cancer detection process.
Development and implementation of a process to support early detection of cancer.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2021 · fourth_quarter · 4A
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2021 · fourth_quarter · Q4
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PMI GLOBAL SERVICES INC. via THE MATHIS HARPLE GROUP
2021 · fourth_quarter · Q4
Taxation of Modified Risk Tobacco Products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2021 · fourth_quarter · Q4
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2021 · fourth_quarter · Q4
S.3023, S.3428, S.2896, HR.5401
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2021 · fourth_quarter · Q4
S.3023, S.3428, S.2896, HR.5401
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2021 · third_quarter · Q3
HR.4549, HR.5376, HR.4879, HR.4720, HR.4834 S.2605, S.2377, S.2373, S.2475
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2021 · third_quarter · Q3
S.2605, S.2377, S.2373, S.2475 HR.4549, HR.5376, HR.4879, HR.4599, HR.4309, HR.4720, HR.4834
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2021 · third_quarter · Q3
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2021 · third_quarter · Q3
Development and implementation of a process to support early detection of cancer.
Provide coverage of the costs of the Grail early cancer detection process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PMI GLOBAL SERVICES INC. via THE MATHIS HARPLE GROUP
2021 · third_quarter · Q3
Taxation of Modified Risk Tobacco Products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2021 · third_quarter · Q3
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2021 · second_quarter · Q2
Development and implementation of a process to support early detection of cancer.
Provide coverage of the costs of the Grail early cancer detection process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PMI GLOBAL SERVICES INC. via THE MATHIS HARPLE GROUP
2021 · second_quarter · 2A
Reduced Risk Products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2021 · second_quarter · Q2
H.R.2263, H.R.848, H.R.1748, H.R.1524, S.2291, S.2118, S.1298, S.685, S.541
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2021 · second_quarter · Q2
S.1862, S.1169, S.1149, S.2291, S.2118, S.1298, S.685, S.541 H.R.3524, H.R. 2506, H.R.1646, H.R.2263, H.R.4024, H.R.848, H.R.1748, H.R.1524
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2021 · second_quarter · Q2
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PMI GLOBAL SERVICES INC. via THE MATHIS HARPLE GROUP
2021 · second_quarter · Q2
Reduced Risk Products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2021 · second_quarter · Q2
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2021 · first_quarter · Q1
Provide coverage of the costs of the Grail early cancer detection process.
Development and implementation of a process to support early detection of cancer.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2021 · first_quarter · Q1
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2021 · first_quarter · Q1
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2021 · first_quarter · Q1
HR 1746, HR 1512, HR 848, HR 2097, HR 1524, HR 541
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2021 · first_quarter · Q1
HR1646; HR1512; HR579; HR806; HR1746; HR848; HR2097; HR1524; HR541
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALTRIA CLIENT SERVICES LLC FKA ALTRIA via THE MATHIS HARPLE GROUP
2020 · third_quarter · RR
Tobacco production rights Development/Allowance of new tobacco based products
GRAIL, INC via THE MATHIS HARPLE GROUP
2020 · fourth_quarter · Q4
Issues related to oncology and early multi-cancer detection, including diagnostics and screening Medicare issues related to oncology and early multi-cancer detection, including diagnostics and screening
Medicare issues issues related to oncology and early multi-cancer detection
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2020 · fourth_quarter · Q4
Price Controls, Importation of Biopharmaceuticals, Patent Protections
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2020 · fourth_quarter · Q4
HR133, S1359, HR5608, S1134, HR2314
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2020 · fourth_quarter · Q4
HR133, HR7613, S4049, S1359, HR2597, HR5608, S CON RES 2, S612, S1127, H CON RES 23, HR1471, S903, S2368, HR2741, HR7247, HR7406, HR5787, S1234, HR1544, HR2699, HR2995, HR3136, S2293, S2338, S1134, S2917, S CON RES 2, S612, S1127, S2293, S2338, H CON RES 23, HR1471, HR3407, HR4863, S649, S1234, S2854, HR1544, HR2699
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2020 · fourth_quarter · 4A
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2020 · fourth_quarter · Q4
Price Controls, Intellectual Property Rights
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PMI GLOBAL SERVICES INC. via THE MATHIS HARPLE GROUP
2020 · third_quarter · Q3
Reduced Risk Products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2020 · third_quarter · Q3
HR 1315, HR. 1760, HR 2741, HR 7814, HR 2314, HR 1544, HR 3136, HR 362 S 1234, S 2368, S 1134
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2020 · third_quarter · Q3
HR 6359, HR.1315, HR.2741, HR.3358, HR.7406, HR.5680, HR.2314, H.Con Res. 23, HR.1471, HR. 3407, HR.4863, HR.1544, HR.3136 S.2368, S.3045, S.1134, S.2293, S.1234, S.2854
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2020 · third_quarter · Q3
Medicare issues issues related to oncology and early multi-cancer detection
Issues related to oncology and early multi-cancer detection, including diagnostics and screening Medicare issues related to oncology and early multi-cancer detection, including diagnostics and screening
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2020 · third_quarter · Q3
Price Controls, Importation of Biopharmaceuticals, Patent Protections
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2020 · third_quarter · Q3
Price Controls, Intellectual Property Rights, Drug Importation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PMI GLOBAL SERVICES INC. via THE MATHIS HARPLE GROUP
2020 · second_quarter · Q2
Reduced Risk Products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2020 · second_quarter · Q2
Medicare issues issues related to oncology and early multi-cancer detection
Issues related to oncology and early multi-cancer detection, including diagnostics and screening Medicare issues related to oncology and early multi-cancer detection, including diagnostics and screening
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via THE MATHIS HARPLE GROUP
2020 · second_quarter · Q2
Price Controls, Importation of Biopharmaceuticals, Patent Protections
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PILMA via THE MATHIS HARPLE GROUP
2020 · second_quarter · Q2
HR 1425, Price Controls, Intellectual Property Rights, Patent Protections
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSTELLATION ENERGY GENERATION, LLC via THE MATHIS HARPLE GROUP
2020 · second_quarter · Q2
HR 1315, HR 1359, HR 1544, HR 2699, HR 3136, HR 362, HR 1315, HR 2741 S 2657, S 1359, S 649, S 1234, S 2917, S 903, S 2368
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NUCLEAR ENERGY INSTITUTE via THE MATHIS HARPLE GROUP
2020 · second_quarter · Q2
HR 1315, HR 6097, HR 1544, HR 2699, HR 3136, H Con Res 23, HR 1471, HR 4863, HR 34, HR 362, HR 1315, HR 1760, HR 2741, HR 3306, HR 3358, HR 5685, HR 5787, HR 6796 S 2657, S 4049, S 1359, HR 2597, S 649, S 1234, S 2917, S 612, S 1127, S 2293, S 2338, S 903, S 2368
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC via THE MATHIS HARPLE GROUP
2020 · second_quarter · RR
HCR - Issues related to oncology and early multi-cancer detection, including diagnostics and screening. MMM- Medicare issues related to oncology and early multi-cancer detection, including diagnostics and screening.
HCR - Issues related to oncology and early multi-cancer detection, including diagnostics and screening. MMM- Medicare issues related to oncology and early multi-cancer detection, including diagnostics and screening.